ArticleVaccines2025

Safety and Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Chinese Children, Adults and the Elderly: A Phase 4, Randomized, Double-Blind, Active-Controlled Clinical Trial.

Xiaoyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.